首页> 外国专利> ORAL DOSAGE FORMS COMPRISING ERODABLE CORE HAVING A COATING WITH ONE OR MORE OPENINGS, AND COMPRISING ROSIGLITAZONE AND METFORMIN OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF AND PROCESS FOR THEIR PREPARATION

ORAL DOSAGE FORMS COMPRISING ERODABLE CORE HAVING A COATING WITH ONE OR MORE OPENINGS, AND COMPRISING ROSIGLITAZONE AND METFORMIN OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF AND PROCESS FOR THEIR PREPARATION

机译:口服剂型,包括具有一个或多个开口的易蚀芯涂层,并包含罗格列酮和二甲双胍或药学上可接受的盐或为其制备的溶剂及其制备方法

摘要

An oral dosage form comprising an erodable core, which core comprises rosiglitazone or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.
机译:包含易蚀核心的口服剂型,该核心包含罗格列酮或其药学上可接受的盐或溶剂化物以及另一种抗糖尿病药,该核心具有带有一个或多个开口的包衣,其特征在于该包衣在预定的pH条件下可被腐蚀;制备这种剂型的方法以及这种剂型在医学中的用途。

著录项

  • 公开/公告号IL173177A

    专利类型

  • 公开/公告日2006-06-11

    原文格式PDF

  • 申请/专利号IL173177

  • 发明设计人

    申请日2006-01-16

  • 分类号A61Knull/null;A61K9/28;A61K45/06;A61P3/10;

  • 国家 IL

  • 入库时间 2022-08-21 21:39:06

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号